At JY BioMed, we provide high-quality Research Use Only (RUO) dendritic cell (DC) products and DC-derived exosomes to support immunological studies and translational research. Dendritic cells are key antigen-presenting cells capable of initiating and regulating adaptive immune responses, making them critical tools in cancer immunotherapy and vaccine development research.

​

Our dendritic cell exosomes carry bioactive molecules involved in immune signaling and are being explored for their potential role in cell-free immunomodulation studies. All products undergo stringent quality assessments, including identity verification and viability testing, to ensure consistency and reproducibility for laboratory research use.